Effect of Breather in COPD Patients With Intermittent Claudication
Recruiting · NCT06529185 · Interventional (participants receive a specific treatment) · Lead sponsor: Cairo University
View the official record on ClinicalTrials.gov →Interventions studied
The BREATHERpharmacological treatment
What this trial is about
The aim of this study To show the effect of breather on ventilatory and vascular function in COPD patient with intermittent claudication.
Who can take part
Age range
50 Years to 60 Years
Sex
Male
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not applicable (e.g. observational or device study)
Study type
Interventional (participants receive a specific treatment)
Inclusion criteria
- sixty male patients with diagnosed with grade I and grade II COPD their ages ranged between 55-60years
- All patients will be clinically and medically stable when attending the study.
- Body mass index (BMI) is 18.5 to 24.9 kg/m2.
- History of unilateral exertional leg pain,
- Ambulation during a graded treadmill test limited by leg pain consistent with intermittent claudication (stage II of the fontaine classification of pad),
- And an ankle-brachial index (ABI) of 0.90 or lower at rest or 0.73 or lower after exercise.
Exclusion criteria
- cardiovascular insufficiency,
- Recent myocardial infarction,
- heart failure,
- arrhythmia,
- DVT,
- Intracranial hypertension,
- Pneumonia,
- kidney failure,
- fractures,
- uncooperative patients,
- cognitive impairment preventing a patient from participation in exercises.
Where it is running
1 location listed.
- Faculty of Physical Therapy - Dokki, Egypt